ArticleTherapeutics and clinical risk management2018

Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy.

Ching-Chih Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.